Skip to main content
Top
Published in: Endocrine 2/2014

Open Access 01-11-2014 | Original Article

The associations between cardiometabolic risk factors and visceral fat measured by a new dual-energy X-ray absorptiometry-derived method in lean healthy Caucasian women

Authors: Tomasz Miazgowski, Barbara Krzyżanowska-Świniarska, Joanna Dziwura-Ogonowska, Krystyna Widecka

Published in: Endocrine | Issue 2/2014

Login to get access

Abstract

Excess visceral adipose tissue (VAT) is associated with a cluster of metabolic abnormalities. A new dual-energy X-ray absorptiometry (DXA)-based VAT measurement approach, CoreScan™, computes VAT mass and volume within the android region of a total body DXA scan. However, there have been no reference values developed for this method. The objective of this study was to determine the normal reference ranges for DXA-derived VAT in young, healthy, premenopausal women. We also sought associations between VAT, blood lipids, glucose, insulin and insulin resistance. In 120 randomly selected, normal weight, Caucasian women aged 20–40 years, we measured body fat (BF), VAT and lean mass by DXA. We also assessed blood pressure, waist and hip circumference, waist-to-hip ratio, body mass index, fasting glucose, insulin, triglycerides (TG), and high- (HDL) and low-density lipoproteins. Insulin resistance was evaluated by the homeostasis model assessment (HOMA). VAT mass accounted for 0.37 ± 0.3 % of weight and 1.11 ± 0.72 % of BF. Mean VAT mass and volume were 235.9 ± 183 g (95 % CI 202.7–269.1) and 250.3 ± 194.5 cm3 (95 % CI 215.1–285.4), respectively. Anthropometric indices moderately correlated with VAT. VAT significantly correlated with HDL (R = −0.193; P = 0.03), glucose (R = 0.252; P = 0.005) and HOMA (R = 0.184; P = 0.049). In this study, we provide normal values of VAT mass and volume measured by DXA and determined for healthy, normal weight, Caucasian women aged 20–40 years. Even in such strictly selected population VAT correlated positively with insulin resistance and inversely with HDL.
Literature
1.
go back to reference K. Indulekha, R.M. Anjana, J. Surendar, V. Mohan, Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clin. Biochem. 44, 281–287 (2011)PubMedCrossRef K. Indulekha, R.M. Anjana, J. Surendar, V. Mohan, Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clin. Biochem. 44, 281–287 (2011)PubMedCrossRef
2.
go back to reference L.K. Meyer, T.P. Ciaraldi, R.R. Henry, A.C. Wittgrove, S.A. Phillips, Adipose tissue depot and cell size dependency of adiponectin synthesis and secretion in human obesity. Adipocyte 2, 217–226 (2013)PubMedCrossRefPubMedCentral L.K. Meyer, T.P. Ciaraldi, R.R. Henry, A.C. Wittgrove, S.A. Phillips, Adipose tissue depot and cell size dependency of adiponectin synthesis and secretion in human obesity. Adipocyte 2, 217–226 (2013)PubMedCrossRefPubMedCentral
3.
go back to reference I.J. Neeland, A.T. Turer, C.R. Ayers, T.M. Powell-Wiley, G.L. Vega, R. Farzaneh-Far, S.M. Grundy, A. Khera, D.K. McGuire, J.A. de Lemos, Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 308, 1150–1159 (2012)PubMedCrossRefPubMedCentral I.J. Neeland, A.T. Turer, C.R. Ayers, T.M. Powell-Wiley, G.L. Vega, R. Farzaneh-Far, S.M. Grundy, A. Khera, D.K. McGuire, J.A. de Lemos, Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 308, 1150–1159 (2012)PubMedCrossRefPubMedCentral
4.
go back to reference S. Yamamoto, T. Nakagawa, Y. Matsushita, S. Kusano, T. Hayashi, M. Irokawa, T. Aoki, Y. Korogi, T. Mizoue, Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia. Diab Care 33, 184–189 (2010)CrossRef S. Yamamoto, T. Nakagawa, Y. Matsushita, S. Kusano, T. Hayashi, M. Irokawa, T. Aoki, Y. Korogi, T. Mizoue, Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia. Diab Care 33, 184–189 (2010)CrossRef
5.
go back to reference E.L. Thomas, G. Frost, S.D. Taylor-Robinson, J.D. Bell, Excess body fat in obese and normal-weight subjects. Nutr. Res. Rev. 25, 150–161 (2012)PubMedCrossRef E.L. Thomas, G. Frost, S.D. Taylor-Robinson, J.D. Bell, Excess body fat in obese and normal-weight subjects. Nutr. Res. Rev. 25, 150–161 (2012)PubMedCrossRef
6.
go back to reference A.D. Karelis, R. Rabasa-Lhoret, R. Pompilus, V. Messier, I. Strychar, M. Brochu, M. Aubertin-Leheudre, Relationship between the Bertin index to estimate visceral adipose tissue from dual-energy X-ray absorptiometry and cardiometabolic risk factors before and after weight loss. Obesity (Silver Spring) 20, 886–890 (2012)CrossRef A.D. Karelis, R. Rabasa-Lhoret, R. Pompilus, V. Messier, I. Strychar, M. Brochu, M. Aubertin-Leheudre, Relationship between the Bertin index to estimate visceral adipose tissue from dual-energy X-ray absorptiometry and cardiometabolic risk factors before and after weight loss. Obesity (Silver Spring) 20, 886–890 (2012)CrossRef
7.
go back to reference E. Bertin, C. Marcus, J.C. Ruiz, J.P. Eschard, M. Leutenegger, Measurement of visceral adipose tissue by DXA combined with anthropometry in obese humans. Int. J. Obes. Relat. Metab. Disord. 24, 263–270 (2000)PubMedCrossRef E. Bertin, C. Marcus, J.C. Ruiz, J.P. Eschard, M. Leutenegger, Measurement of visceral adipose tissue by DXA combined with anthropometry in obese humans. Int. J. Obes. Relat. Metab. Disord. 24, 263–270 (2000)PubMedCrossRef
8.
go back to reference S. Kaul, M.P. Rothney, D.M. Peters, W.K. Wacker, C.E. Davis, M.D. Shapiro, D.L. Ergun, Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity (Silver Spring) 20, 1313–1318 (2012)CrossRef S. Kaul, M.P. Rothney, D.M. Peters, W.K. Wacker, C.E. Davis, M.D. Shapiro, D.L. Ergun, Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity (Silver Spring) 20, 1313–1318 (2012)CrossRef
9.
go back to reference R.C. Turner, R.R. Holman, D. Matthews, T.D. Hockaday, J. Peto, Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism 28, 1086–1096 (1979)PubMedCrossRef R.C. Turner, R.R. Holman, D. Matthews, T.D. Hockaday, J. Peto, Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism 28, 1086–1096 (1979)PubMedCrossRef
11.
go back to reference D.L. Ergun, M.P. Rothney, M.K. Oates, Y. Xia, W.K. Wacker, N.C. Binkley, Visceral adipose tissue quantification using lunar prodigy. J. Clin. Densitom. 16, 75–78 (2013)PubMedCrossRef D.L. Ergun, M.P. Rothney, M.K. Oates, Y. Xia, W.K. Wacker, N.C. Binkley, Visceral adipose tissue quantification using lunar prodigy. J. Clin. Densitom. 16, 75–78 (2013)PubMedCrossRef
12.
go back to reference M. Lagerpusch, A. Bosy-Westphal, B. Kehden, A. Peters, M.J. Müller, Effects of brief perturbations in energy balance on indices of glucose homeostasis in healthy lean men. Int. J. Obes. (Lond) 36, 1094–1101 (2012)CrossRef M. Lagerpusch, A. Bosy-Westphal, B. Kehden, A. Peters, M.J. Müller, Effects of brief perturbations in energy balance on indices of glucose homeostasis in healthy lean men. Int. J. Obes. (Lond) 36, 1094–1101 (2012)CrossRef
13.
go back to reference P. Singh, V.K. Somers, A. Romero-Corral, F.H. Sert-Kuniyoshi, S. Pusalavidyasagar, D.E. Davison, M.D. Jensen, Effects of weight gain and weight loss on regional fat distribution. Am. J. Clin. Nutr. 96, 229–233 (2012)PubMedCrossRefPubMedCentral P. Singh, V.K. Somers, A. Romero-Corral, F.H. Sert-Kuniyoshi, S. Pusalavidyasagar, D.E. Davison, M.D. Jensen, Effects of weight gain and weight loss on regional fat distribution. Am. J. Clin. Nutr. 96, 229–233 (2012)PubMedCrossRefPubMedCentral
14.
go back to reference C.S. Fox, J.M. Massaro, U. Hoffmann, K.M. Pou, P. Maurovich-Horvat, C.Y. Liu, R.S. Vasan, J.M. Murabito, J.B. Meigs, L.A. Cupples, R.B. D’Agostino, Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116, 39–48 (2007)PubMedCrossRef C.S. Fox, J.M. Massaro, U. Hoffmann, K.M. Pou, P. Maurovich-Horvat, C.Y. Liu, R.S. Vasan, J.M. Murabito, J.B. Meigs, L.A. Cupples, R.B. D’Agostino, Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116, 39–48 (2007)PubMedCrossRef
15.
go back to reference G.L. Vega, B. Adams-Huet, R. Peshock, D. Willett, B. Shah, S.M. Grundy, Influence of body fat content and distribution on variation in metabolic risk. J. Clin. Endocrinol. Metab. 91, 4459–4466 (2006)PubMedCrossRef G.L. Vega, B. Adams-Huet, R. Peshock, D. Willett, B. Shah, S.M. Grundy, Influence of body fat content and distribution on variation in metabolic risk. J. Clin. Endocrinol. Metab. 91, 4459–4466 (2006)PubMedCrossRef
16.
go back to reference B.H. Goodpaster, S. Krishnaswami, T.B. Harris, A. Katsiaras, S.B. Kritchevsky, E.M. Simonsick, M. Nevitt, P. Holvoet, A.B. Newman, Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch. Intern. Med. 165, 777–783 (2005)PubMedCrossRef B.H. Goodpaster, S. Krishnaswami, T.B. Harris, A. Katsiaras, S.B. Kritchevsky, E.M. Simonsick, M. Nevitt, P. Holvoet, A.B. Newman, Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch. Intern. Med. 165, 777–783 (2005)PubMedCrossRef
17.
go back to reference J.A. Seo, B.G. Kim, H. Cho, H.S. Kim, J. Park, S.H. Baik, D.S. Choi, M.H. Park, S.A. Jo, Y.H. Koh, C. Han, N.H. Kim, The cutoff values of visceral fat area and waist circumference for identifying subjects at risk for metabolic syndrome in elderly Korean: Ansan Geriatric (AGE) cohort study. BMC Public Health 9, 443 (2009)PubMedCrossRefPubMedCentral J.A. Seo, B.G. Kim, H. Cho, H.S. Kim, J. Park, S.H. Baik, D.S. Choi, M.H. Park, S.A. Jo, Y.H. Koh, C. Han, N.H. Kim, The cutoff values of visceral fat area and waist circumference for identifying subjects at risk for metabolic syndrome in elderly Korean: Ansan Geriatric (AGE) cohort study. BMC Public Health 9, 443 (2009)PubMedCrossRefPubMedCentral
18.
go back to reference P.J. Pickhardt, Y. Jee, S.D. O’Connor, A.M. del Rio, Visceral adiposity and hepatic steatosis at abdominal CT: association with the metabolic syndrome. AJR Am. J. Roentgenol. 198, 1100–1107 (2012)PubMedCrossRef P.J. Pickhardt, Y. Jee, S.D. O’Connor, A.M. del Rio, Visceral adiposity and hepatic steatosis at abdominal CT: association with the metabolic syndrome. AJR Am. J. Roentgenol. 198, 1100–1107 (2012)PubMedCrossRef
19.
go back to reference A. Bazzocchi, D. Diano, F. Ponti, A. Andreone, C. Sassi, U. Albisinni, G. Marchesini, G. Battista, Health and ageing: a cross-sectional study of body composition. Clin. Nutr. 32, 569–578 (2012)PubMedCrossRef A. Bazzocchi, D. Diano, F. Ponti, A. Andreone, C. Sassi, U. Albisinni, G. Marchesini, G. Battista, Health and ageing: a cross-sectional study of body composition. Clin. Nutr. 32, 569–578 (2012)PubMedCrossRef
20.
go back to reference G. Bednarek-Tupikowska, B. Stachowska, T. Miazgowski, B. Krzyżanowska-Świniarska, B. Katra, M. Jaworski, J. Kuliczkowska-Płaksej, A. Jokiel-Rokita, M. Tupikowska, M. Bolanowski, D. Jędrzejuk, A. Milewicz, Evaluation of the prevalence of metabolic obesity and normal weight among the Polish population. Endokrynol. Pol. 63, 447–455 (2012)PubMed G. Bednarek-Tupikowska, B. Stachowska, T. Miazgowski, B. Krzyżanowska-Świniarska, B. Katra, M. Jaworski, J. Kuliczkowska-Płaksej, A. Jokiel-Rokita, M. Tupikowska, M. Bolanowski, D. Jędrzejuk, A. Milewicz, Evaluation of the prevalence of metabolic obesity and normal weight among the Polish population. Endokrynol. Pol. 63, 447–455 (2012)PubMed
21.
go back to reference S. Mariani, D. Fiore, G. Barbaro, S. Basciani, M. Saponara, E. D’Arcangelo, S. Ulisse, C. Moretti, A. Fabbri, L. Gnessi, Association of epicardial fat thickness with the severity of obstructive sleep apnea in obese patients. Int. J. Cardiol. 167, 2244–2249 (2013)PubMedCrossRef S. Mariani, D. Fiore, G. Barbaro, S. Basciani, M. Saponara, E. D’Arcangelo, S. Ulisse, C. Moretti, A. Fabbri, L. Gnessi, Association of epicardial fat thickness with the severity of obstructive sleep apnea in obese patients. Int. J. Cardiol. 167, 2244–2249 (2013)PubMedCrossRef
22.
go back to reference C. Lubrano, M. Saponara, G. Barbaro, P. Specchia, E. Addessi, D. Costantini, M. Tenuta, G. Di Lorenzo, G. Genovesi, L.M. Donini, A. Lenzi, L. Gnessi, Relationships between body fat distribution, epicardial fat and obstructive sleep apnea in obese patients with and without metabolic syndrome. PLoS One 7, e47059 (2012)PubMedCrossRefPubMedCentral C. Lubrano, M. Saponara, G. Barbaro, P. Specchia, E. Addessi, D. Costantini, M. Tenuta, G. Di Lorenzo, G. Genovesi, L.M. Donini, A. Lenzi, L. Gnessi, Relationships between body fat distribution, epicardial fat and obstructive sleep apnea in obese patients with and without metabolic syndrome. PLoS One 7, e47059 (2012)PubMedCrossRefPubMedCentral
Metadata
Title
The associations between cardiometabolic risk factors and visceral fat measured by a new dual-energy X-ray absorptiometry-derived method in lean healthy Caucasian women
Authors
Tomasz Miazgowski
Barbara Krzyżanowska-Świniarska
Joanna Dziwura-Ogonowska
Krystyna Widecka
Publication date
01-11-2014
Publisher
Springer US
Published in
Endocrine / Issue 2/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0180-7

Other articles of this Issue 2/2014

Endocrine 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine